FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2024/05/068208 [Registered on: 31/05/2024] Trial Registered Prospectively
Last Modified On: 28/05/2024
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Drug
Surgical/Anesthesia 
Study Design  Randomized, Parallel Group, Active Controlled Trial 
Public Title of Study   To assess the time of onset and efficacy of sensory and motor blockade and post operative pain when two different Adjuvants are added to hyperbaric levobupivacaine for spinal anaesthesia to pregnant patients undergoing caesarean section  
Scientific Title of Study   Efficacy of Fentanyl and Butorphanol as adjuvant with 0.5% Hyperbaric Levobupivacaine in caesarean section A Randomised Controlled Double Blind Study  
Trial Acronym  Nil 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Dr PITHANI VAMSEE PRIYA 
Designation  Post Graduate Trainee 
Affiliation  Kalinga Institute Of Medical Sciences  
Address  Department of Anaesthesiology, 3rd floor, PBMH , KIMS , KIIT University , Bhubaneswar , Khordha, Orissa 751024 India

Khordha
ORISSA
751024
India 
Phone  8498882244  
Fax    
Email  pithani1111@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Dr Pramod Patra 
Designation  Professor 
Affiliation  Kalinga Institute Of Medical Sciences 
Address  Department of Anaesthesiology, 3rd floor, PBMH , KIMS , KIIT University , Bhubaneswar , Khordha, Orissa 751024 India

Khordha
ORISSA
751024
India 
Phone  9439616053  
Fax    
Email  pramod.patra@gmail.com  
 
Details of Contact Person
Public Query
 
Name  Dr Pramod Patra 
Designation  Professor 
Affiliation  Kalinga Institute Of Medical Sciences 
Address  Department of Anaesthesiology, 3rd floor, PBMH , KIMS , KIIT University , Bhubaneswar , Khordha, Orissa 751024 India

Khordha
ORISSA
751024
India 
Phone  9439616053  
Fax    
Email  pramod.patra@gmail.com  
 
Source of Monetary or Material Support  
Kalinga Institute Of Medical Sciences Bhubaneswar Odisha India 751024 
 
Primary Sponsor  
Name  Pithani Vamsee Priya 
Address  Kalinga Institute Of Medical Sciences Patia BHUBANESWAR Odisha India 751024  
Type of Sponsor  Other [Self] 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Pithani Vamsee Priya  Kalinga Institute Of Medical Sciences  Department of Anaesthesiology 3rd Floor, KIMS, Bhubaneswar.
Khordha
ORISSA 
8498882244

2387015@kims.ac.in 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
INSTITUTIONAL ETHICS COMMITTE KALINGA INSTITUTE OF MEDICAL SCIENCES  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition: O||Medical and Surgical, (2) ICD-10 Condition: Z331||Pregnant state, incidental,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Intervention  Butorphanol  Frequency-A single dose Dose-0.5mL(0.5mg)Butorphanol is added to 2ml of 0.5% hyperbaric Levobupivacaine Route-Intrathecal duration of intervention- The assessment of effects of the butorphanol with levobupivacaine will be for a duration of 6 hours from the time of injection as per different intervals mentioned in the methodology  
Comparator Agent  Fentanyl  Frequency-A single dose Dose-0.5mL(25mcg) of Fentanyl is added to 2mL of 0.5% hyperbaric Levobupivacaine Route-Intrathecal duration of intervention- The assessment of effects of the fentanyl with levobupivacaine will be for a duration of 6 hours from the time of injection as per different intervals mentioned in the methodology  
 
Inclusion Criteria  
Age From  18.00 Year(s)
Age To  40.00 Year(s)
Gender  Female 
Details  Pregnant females posted for LSCS under spinal anaesthesia
ASA-II 
 
ExclusionCriteria 
Details  Patients not willing to be part of study
Contraindications of subarachnoid block
Allergy to local anaesthesia
Twin pregnancies
Polyhydramnios 
 
Method of Generating Random Sequence   Computer generated randomization 
Method of Concealment   Sequentially numbered, sealed, opaque envelopes 
Blinding/Masking   Participant and Investigator Blinded 
Primary Outcome  
Outcome  TimePoints 
Sensory block(In seconds)  The onset of sensory block will be assessed with a pinprick test (using a blunt 25-gauge needle along the mid-clavicular line bilaterally) every 15 seconds from time of subarachnoid block until T6 level achieved.  
 
Secondary Outcome  
Outcome  TimePoints 
1.2 segment regression (in minutes)
2.Duration of sensory block(in minutes)
3.Post operative analgesia(in minutes) 
1.The time taken for sensory level to regress to 2 segment below(T8) highest level(T6) will be considered as 2 segment regression for the patient. 2.Duration of sensory block defined as time taken for sensory block to regress 2 segments below from time of subarachnoid block
3.Pain will be assessed by using visual analogue scale (VAS); at 15 minutes 30 minutes and thereafter every 30 minutes till two hours postoperatively and then every hourly, till six hours postoperatively 
 
Target Sample Size   Total Sample Size="160"
Sample Size from India="80" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   Phase 4 
Date of First Enrollment (India)   15/06/2024 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="2"
Months="1"
Days="1" 
Recruitment Status of Trial (Global)   Not Applicable 
Recruitment Status of Trial (India)  Open to Recruitment 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary  
Since levobupivacaine is being used as a safer alternative to bupivacaine plain in spinal anesthesia for caesarean section,there are very limited studies comparing efficacy of butorphanol and fentanyl as adjuvants to levobupivacaine in caesarean section and hence this study is taken up to assess the changes in efficacy of both these opioid drugs when used as adjuvant with levobupivacaine
 
Close